• Je něco špatně v tomto záznamu ?

Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection

P. Kaeopookum, D. Summer, J. Pfister, T. Orasch, BE. Lechner, M. Petrik, Z. Novy, B. Matuszczak, C. Rangger, H. Haas, C. Decristoforo,

. 2019 ; 21 (6) : 1097-1106. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023431

Grantová podpora
P 30924 Austrian Science Fund FWF - Austria

E-zdroje Online Plný text

NLK ProQuest Central od 2005-01-01 do 2019-01-31
Medline Complete (EBSCOhost) od 2011-02-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2005-01-01 do 2019-01-31
Health & Medicine (ProQuest) od 2005-01-01 do 2019-01-31

Odkazy

PubMed 30838551
DOI 10.1007/s11307-019-01325-6
Knihovny.cz E-zdroje

PURPOSE: Aspergillus fumigatus produces the siderophore triacetylfusarinine C (TAFC) for iron acquisition which is essential for its virulence. Therefore, TAFC is a specific marker for invasive aspergillosis. We have shown previously that positron emission tomography (PET) imaging with [68Ga]TAFC exhibited excellent targeting properties in an A. fumigatus rat infection model. In this study, we aimed to prepare TAFC analogs modifying fusarinine C (FSC) by acylation with different carbon chain lengths as well as with charged substituents and investigated the influence of introduced substituents on preservation of TAFC characteristics in vitro and in vivo. PROCEDURES: Fifteen TAFC derivatives were prepared and labeled with gallium-68. In vitro uptake assays were carried out in A. fumigatus under iron-replete as well as iron-depleted conditions and distribution coefficient was determined. Based on these assays, three compounds, [68Ga]tripropanoyl(FSC) ([68Ga]TPFC), [68Ga]diacetylbutanoyl(FSC) ([68Ga]DABuFC), and [68Ga]trisuccinyl(FSC) ([68Ga]FSC(suc)3), with high, medium, and low in vitro uptake in fungal cultures, were selected for further evaluation. Stability and protein binding were evaluated and in vivo imaging performed in the A. fumigatus rat infection model. RESULTS: In vitro uptake studies using A. fumigatus revealed specific uptake of mono- and trisubstituted TAFC derivatives at RT. Lipophilicities as expressed by logD were 0.34 to - 3.80. The selected compounds displayed low protein binding and were stable in PBS and serum. Biodistribution and image contrast in PET/X-ray computed tomography of [68Ga]TPFC and [68Ga]DABuFC were comparable to [68Ga]TAFC, whereas no uptake in the infected region was observed with [68Ga]FSC(suc)3. CONCLUSIONS: Our studies show the possibility to modify TAFC without losing its properties and specific recognition by A. fumigatus. This opens also new ways for multimodality imaging or theranostics of fungal infection by introducing functionalities such as fluorescent dyes or antifungal moieties.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023431
003      
CZ-PrNML
005      
20201214130026.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11307-019-01325-6 $2 doi
035    __
$a (PubMed)30838551
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kaeopookum, Piriya $u Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria. Research and Development Division, Thailand Institute of Nuclear Technology, Nakhon Nayok, Thailand.
245    10
$a Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection / $c P. Kaeopookum, D. Summer, J. Pfister, T. Orasch, BE. Lechner, M. Petrik, Z. Novy, B. Matuszczak, C. Rangger, H. Haas, C. Decristoforo,
520    9_
$a PURPOSE: Aspergillus fumigatus produces the siderophore triacetylfusarinine C (TAFC) for iron acquisition which is essential for its virulence. Therefore, TAFC is a specific marker for invasive aspergillosis. We have shown previously that positron emission tomography (PET) imaging with [68Ga]TAFC exhibited excellent targeting properties in an A. fumigatus rat infection model. In this study, we aimed to prepare TAFC analogs modifying fusarinine C (FSC) by acylation with different carbon chain lengths as well as with charged substituents and investigated the influence of introduced substituents on preservation of TAFC characteristics in vitro and in vivo. PROCEDURES: Fifteen TAFC derivatives were prepared and labeled with gallium-68. In vitro uptake assays were carried out in A. fumigatus under iron-replete as well as iron-depleted conditions and distribution coefficient was determined. Based on these assays, three compounds, [68Ga]tripropanoyl(FSC) ([68Ga]TPFC), [68Ga]diacetylbutanoyl(FSC) ([68Ga]DABuFC), and [68Ga]trisuccinyl(FSC) ([68Ga]FSC(suc)3), with high, medium, and low in vitro uptake in fungal cultures, were selected for further evaluation. Stability and protein binding were evaluated and in vivo imaging performed in the A. fumigatus rat infection model. RESULTS: In vitro uptake studies using A. fumigatus revealed specific uptake of mono- and trisubstituted TAFC derivatives at RT. Lipophilicities as expressed by logD were 0.34 to - 3.80. The selected compounds displayed low protein binding and were stable in PBS and serum. Biodistribution and image contrast in PET/X-ray computed tomography of [68Ga]TPFC and [68Ga]DABuFC were comparable to [68Ga]TAFC, whereas no uptake in the infected region was observed with [68Ga]FSC(suc)3. CONCLUSIONS: Our studies show the possibility to modify TAFC without losing its properties and specific recognition by A. fumigatus. This opens also new ways for multimodality imaging or theranostics of fungal infection by introducing functionalities such as fluorescent dyes or antifungal moieties.
650    _2
$a zvířata $7 D000818
650    _2
$a Aspergillus fumigatus $x fyziologie $7 D001232
650    _2
$a krevní proteiny $x metabolismus $7 D001798
650    _2
$a železité sloučeniny $x chemie $7 D005290
650    _2
$a radioizotopy galia $x chemie $7 D005710
650    _2
$a lidé $7 D006801
650    _2
$a kyseliny hydroxamové $x chemie $7 D006877
650    _2
$a myši inbrední BALB C $7 D008807
650    12
$a molekulární zobrazování $7 D057054
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a mykózy $x diagnostické zobrazování $x mikrobiologie $7 D009181
650    _2
$a PET/CT $7 D000072078
650    _2
$a vazba proteinů $7 D011485
650    _2
$a plicní aspergilóza $x diagnostické zobrazování $x mikrobiologie $7 D055732
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a siderofory $x chemická syntéza $x chemie $7 D017262
650    _2
$a tkáňová distribuce $7 D014018
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Summer, Dominik $u Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
700    1_
$a Pfister, Joachim $u Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
700    1_
$a Orasch, Thomas $u Division of Molecular Biology, Biocenter, Medical University Innsbruck, Innsbruck, Austria.
700    1_
$a Lechner, Beatrix E $u Division of Molecular Biology, Biocenter, Medical University Innsbruck, Innsbruck, Austria.
700    1_
$a Petrik, Milos $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Novy, Zbynek $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic.
700    1_
$a Matuszczak, Barbara $u Institute of Pharmacy, Pharmaceutical Chemistry, University of Innsbruck, Innsbruck, Austria.
700    1_
$a Rangger, Christine $u Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
700    1_
$a Haas, Hubertus $u Division of Molecular Biology, Biocenter, Medical University Innsbruck, Innsbruck, Austria.
700    1_
$a Decristoforo, Clemens $u Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria. clemens.decristoforo@i-med.ac.at.
773    0_
$w MED00008643 $t Molecular imaging and biology $x 1860-2002 $g Roč. 21, č. 6 (2019), s. 1097-1106
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30838551 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214130025 $b ABA008
999    __
$a ok $b bmc $g 1595750 $s 1114107
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 21 $c 6 $d 1097-1106 $e - $i 1860-2002 $m Molecular imaging and biology $n Mol Imaging Biol $x MED00008643
GRA    __
$a P 30924 $p Austrian Science Fund FWF $2 Austria
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace